On May 1st, thought leaders from the ISEV and ISCT published online in Cytotherapy a joint statement, “ISEV and ISCT statement on EVs from MSCs and other cells: considerations for potential ... More

Authored by: Jon Carson, Iain Farrance, John Getz, and Jon A. Rowley, RoosterBio, Inc. On 31-December-2019, Chinese officials alerted the World Health Organization of an outbreak of pneumonia cases in ... More

The use of human mesenchymal stem/stromal cells (hMSCs) has evolved since its discovery in the early 1960s. Continuous learning about hMSCs has shifted the paradigm of theses cells. While originally ... More

Answered by: Amy Permenter, Technical Support Specialist and Tom Rogers, Director, Global Customer Support 1. Do you have a sales representative in my state or country? Yes! RoosterBio has four ... More

We’re thrilled to share that we’ve been named a Frederick County Best Places to Work! This award is especially meaningful to us because our company was built with culture in ... More

Authored by Joseph Candiello, Ph.D., Technical Application Specialist Human Mesenchymal Stem/Stromal Cells (hMSCs) are a critical starting material in a growing variety of established and emerging applications spanning the Regenerative ... More

@JennWebb recently wrote an article for the O’Reilly Radar titled Democratizing Technology and the Road to Empowerment.  She starts out the article with a nice summary of what it means ... More

Everyone at RoosterBio is extremely excited to be launching our company, shipping our first products, and interacting with tissue engineers, cell therapists, synthetic biologists, and our customers to learn about ... More